Loading…
Pall Corporation was selected by Servier as the exclusive technology and services provider for Servier's new biomanufacturing facility in Gidy, France. Pall will provide end-to-end biomanufacturing solutions for monoclonal antibodies and recombinant proteins. The Bio-S project includes up to 2,000L bioreactor capacity, with the Bio-engineering unit operational by 2019 and the rest by 2020.